Skip Navigation

Shi-Yong Sun, PhD

Emory School of Medicine

Dr. Sun earned his PhD in cancer pharmacology at Peking Union Medical College/Chinese Academy of Medical Sciences in China in 1990 and received his postdoctoral training in cancer biology at the University of Texas M.D. Anderson Cancer Center in Houston, Texas. He started his faculty career in 1999 and joined in the Emory in 2003. Dr. Sun  is currently a tenured Associate Professor and Georgia Cancer Coalition Distinguished Cancer Scholar. He is a recipient of numerous peer-reviewed grant awards including NIH/NCI R01, P01 and SPORE. He is on the editorial boards of 12 cancer-related journals and has published extensively in prominent peer-reviewed journals.

Research Interests

The long-term goal of Dr. Sun’s lab is to identify and develop novel and efficacious therapeutic agents or regimens to treat cancer through fully understanding the biology of cancer, particularly pathways that support the survival and growth of cancer cells. Dr. Sun’s lab primarily focuses on studying regulation of death receptors, particularly TRAIL receptors, by small cancer therapeutic molecules and their implications in drug-induced apoptosis and cancer therapy. His lab is also interested in Akt/mTOR signaling and in targeting this signaling pathway for cancer therapy.

Web Site(s):